Asieris(SH:688176) Zheng Quan Zhi Xing·2025-06-20 09:45Meeting Overview - The second meeting of the Supervisory Board of Jiangsu Yahon Pharmaceutical Technology Co., Ltd. was held on June 20, 2025, with full attendance of all three supervisors [1]. Resolutions Passed - The Supervisory Board approved the proposal to annul part of the restricted stock from the 2022 incentive plan that had been granted but not yet vested, confirming compliance with relevant laws and regulations [1][2]. - The Board also approved the conditions for the second vesting period of the initial grant and the first vesting period of the reserved grant under the 2022 incentive plan, stating that the conditions had been met [2][3]. - The company agreed to provide guarantees for its wholly-owned subsidiaries, Shanghai Yahon Pharmaceutical Technology Co., Ltd. and Hainan Yahon Pharmaceutical Trading Co., Ltd., for a total bank credit limit not exceeding RMB 150 million, which represents 7.62% of the company's latest audited net assets [3].